Capromab

We can tell you that Capromab is a…

• …Drug
• …Medical Treatment

If you know more about Capromab, you can add more facts here »

Similar topics in Freebase

• Fanolesomab

  Technetium (Tc) fanolesomab (trade name NeutroSpec, manufactured by Palatin Technologies) is a mouse monoclonal antibody formerly used to aid in the diagnosis of appendicitis. It is labeled with a radioisotope, technetium-99m (Tc). NeutroSpec was approved by the U.S. Food and Drug Administration ...

• Nofetumomab merpentan

  Technetium (Tc) nofetumomab merpentan (trade name Verluma) is a mouse monoclonal antibody used in the diagnosis of lung cancer, gastrointestinal, breast, ovary, pancreas, kidney, cervix, and bladder carcinoma. Nofetumomab has a chelator, merpentan, which links it to a radioisotope, technetium-99m ...

• Muromonab

  Muromonab-CD3 (generic name) is a monoclonal antibody (mAb), also known as Orthoclone OKT3 (Brand name). It is a mouse-derived (murine) monoclonal antibody that specifically binds to the CD3 (T3) protein found on the surface of T cells. Of historical note is that this was the first mAb approved...

• Edrecolomab

  Edrecolomab (MAb17-1A, trade name Panorex) is a chimeric mouse/human monoclonal antibody to the cell-surface glycoprotein EpCAM (17-1A), which is expressed on epithelial tissues and on various carcinomas. Preliminary studies had shown promise of a possible use in patients with stage III colorectal...

• Arcitumomab

  Technetium (Tc) arcitumomab (trade name CEA-Scan) is a drug used to detect gastrointestinal cancers. It consists of a mouse monoclonal antibody (arcitumomab) and a radionuclide, technetium-99m. Arcitumomab recognizes carcinoembryonic antigen (CEA), a commonly expressed antigen in gastrointestinal...

• Tositumomab

  Tositumomab is a monoclonal antibody derived from immortalized mouse cells. It is a IgG2a anti-CD20 antibody and is covalently bound to I. I emits both beta and gamma radiation and decays with a half-life of 8 days. Clinical trials have established the efficacy of tositumomab in patients with...